Literature DB >> 10571789

Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder.

T Imasawa1, R Nagasawa, Y Utsunomiya, T Kawamura, Y Zhong, N Makita, E Muso, S Miyawaki, N Maruyama, T Hosoya, O Sakai, T Ohno.   

Abstract

BACKGROUND: The pathogenesis of IgA nephropathy is still obscure. The aim of this study was to investigate whether the fundamental pathogenesis of IgA nephropathy lies in bone marrow stem cells (BMCs).
METHODS: We used donors of two different strains for bone marrow transplantation (BMT) into mice with a high content of serum IgA (ddY strain, HIGA mice), a murine model of IgA nephropathy. One group (B6-->HIGA, N = 5) received BMCs of C57BL/6j (B6) mice, and the other (HIGA-->HIGA, N = 8) were reconstituted with BMCs of HIGA mice.
RESULTS: Twenty-six weeks after BMT, in B6-->HIGA mice, mesangial deposits of IgA and C3 were statistically milder than those in HIGA-->HIGA mice. Light microscopic observations disclosed that glomerular sclerosis and mesangial matrix expansion in B6-->HIGA mice were decreased compared with those in HIGA-->HIGA mice. These B6-->HIGA mice also excreted less urinary albumin than HIGA-->HIGA mice. Furthermore, serum levels of IgA in B6-->HIGA mice were markedly lower than those in HIGA-->HIGA mice. Size analysis of serum IgA revealed that macromolecular IgA were notably lower in B6-->HIGA mice than in HIGA-->HIGA mice.
CONCLUSIONS: Our results suggest that qualitative and quantitative changes of serum IgA are determined at the level of stem cells, and that BMT from normal donors can attenuate glomerular lesions in HIGA mice. This approach may offer a new avenue to study the pathogenesis of IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571789     DOI: 10.1046/j.1523-1755.1999.00750.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy.

Authors:  Masahiro Muto; Benoit Manfroi; Hitoshi Suzuki; Kensuke Joh; Masaaki Nagai; Sachiko Wakai; Christian Righini; Masayuki Maiguma; Shozo Izui; Yasuhiko Tomino; Bertrand Huard; Yusuke Suzuki
Journal:  J Am Soc Nephrol       Date:  2016-12-05       Impact factor: 10.121

Review 2.  Pathogenetic and therapeutic approaches to IgA nephropathy using a spontaneous animal model, the ddY mouse.

Authors:  Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2010-11-06       Impact factor: 2.801

Review 3.  Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; A Boldt; U Sack; J Fahnert
Journal:  Clin Exp Immunol       Date:  2016-09-08       Impact factor: 4.330

4.  Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.

Authors:  F M Rasche; F Keller; W G Rasche; S Schiekofer; T Kahn; J Fahnert
Journal:  Clin Exp Immunol       Date:  2015-11-26       Impact factor: 4.330

5.  Granulocyte/macrophage origin of glomerular mesangial cells.

Authors:  Takanori Abe; Paul A Fleming; Masahiro Masuya; Hitoshi Minamiguchi; Yasuhiro Ebihara; Christopher J Drake; Makio Ogawaa
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

Review 6.  Progenitor/stem cells in renal regeneration and mass lesions.

Authors:  Ping L Zhang; Jason M Hafron
Journal:  Int Urol Nephrol       Date:  2014-09-03       Impact factor: 2.370

7.  Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia.

Authors:  Akihiro Hoshino; Masaki Shimizu; Hiroyoshi Matsukura; Hisano Sakaki-Nakatsubo; Keiko Nomura; Toshio Miyawaki; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2013-11-12       Impact factor: 8.317

Review 8.  Progression and regression in renal vascular and glomerular fibrosis.

Authors:  Christos Chatziantoniou; Jean-Jacques Boffa; Pierre-Louis Tharaux; Martin Flamant; Pierre Ronco; Jean-Claude Dussaule
Journal:  Int J Exp Pathol       Date:  2004-02       Impact factor: 1.925

Review 9.  Are therapeutic stem cells justified in bilateral multicystic kidney disease? A review of literature with insights into the embryology.

Authors:  Shilpa Sharma; Devendra K Gupta; Lalit Kumar; A K Dinda; A Bagga; S Mohanty
Journal:  Pediatr Surg Int       Date:  2007-06-14       Impact factor: 1.827

10.  Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy.

Authors:  Tadahiro Kajiyama; Yusuke Suzuki; Masao Kihara; Hitoshi Suzuki; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Clin Dev Immunol       Date:  2011-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.